PRO-1041-US-EN-v3
Microlyte® PainGuard™
Reducing infection risk and pain with one solution
A synthetic antimicrobial matrix containing ionic and metallic silver at low, non-toxic levels — providing a 99.99% reduction of a broad range of microbes on the matrix while releasing a uniform, unit-dose of lidocaine HCl for simultaneous pain relief.
Two Solutions, One Matrix
Infection Risk Reduction Meets Pain Relief
Microlyte® PainGuard™ pairs broad-spectrum antimicrobial silver with a uniform unit-dose of lidocaine in a single, conformable matrix.
99.99%
Microbe reduction
Reduction of a broad range of microbes on the matrix from ionic and metallic silver (in vitro).
>80%
Lidocaine release
More than 80% of lidocaine HCl released within the first 30 minutes of application.
Unit-dose
Lidocaine delivery
Releases a uniform, unit-dose of lidocaine HCl for simultaneous pain relief.
Resorbable
Synthetic matrix
Thin, porous matrix of resorbable polymers designed to mimic human ECM.
Engineered to Mimic Human ECM
A synthetic, thin, porous matrix made of resorbable polymers, designed to conform with transparency to the microtextures of the wound bed.
Conforms with Transparency
Conforms with transparency to the microtextures of the wound bed for clear visualization and contact.
Synthetic Porous Matrix
A synthetic, thin, porous matrix made of resorbable polymers, designed to mimic human ECM.
Designed for Pain Relief
More than 80% release of lidocaine HCl within the first 30 minutes to assist in pain relief.
Available Sizes
Three sizes deliver a uniform unit-dose of lidocaine HCl scaled to wound coverage.
| Size | SKU | Wound Coverage | Lidocaine / Piece |
|---|---|---|---|
| 3 × 3 cm | I-MLPG0303 | 9 cm² | 3.6 mg |
| 5 × 5 cm | I-MLPG0505 | 25 cm² | 10 mg |
| 10 × 10 cm | I-MLPG1010 | 100 cm² | 40 mg |
References & Clearance
Microlyte® PainGuard™ is supported by data on file and FDA 510(k) clearance.
Microlyte Shelf Life and Stability
Data on file, Imbed Biosciences
Measurement of Antimicrobial Activity of Microlyte Ag
Data on file, Imbed Biosciences
Surfaces modified with nanometer-thick silver impregnated polymeric films that kill bacteria but support growth of mammalian cells
Agarwal A, et al. (2010)
Biomaterials. 2010;31(4):680-90.
Product Handleability Evaluation Report
Data on file, Imbed Biosciences
Systemic Toxicity, Local Tissue Response, and Wound Healing Study of Microlyte Ag Following Repeated Treatment to Full-Thickness Wounds in Rats – 28 Days
Data on file, Imbed Biosciences
510(k) Summary K211943: Microlyte Ag/Lidocaine
U.S. Food and Drug Administration (2021)
FDA.gov. Published July 2021.
† As demonstrated in vitro.
Reduce Infection Risk. Relieve Pain.
Partner with DermaLynx to bring Microlyte® PainGuard™ and our complete portfolio of advanced wound care solutions to your practice.